Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

European marketing application submitted for RenaGel

July 10, 1998

Ditropan XL shows favorable efficacy/side effect profile in phase III study

July 8, 1998

Blockade of angiotensin II receptor reduces radiation-induced renal and lung injury

July 7, 1998

P&U characterizes dual inhibitor of both 5alpha-reductase isozymes

July 3, 1998

Positive preliminary results reported for extended-use clinical trial of RenaGel

July 3, 1998

Nippon Shinyaku discovers new treatment for urinary incontinence

June 12, 1998

ET antagonist protects against ciclosporin-induced nephrotoxicity in rats

June 11, 1998

New and established treatments for BPH reviewed at AUA

June 10, 1998

Urinary reflux product enters phase III

June 9, 1998

Dornier's BPH device approved by FDA

June 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...